Page last updated: 2024-09-04

beta-lactams and Burns

beta-lactams has been researched along with Burns in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's7 (70.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Adams, W; Baldea, A; Bouchard, C; de Bustros, P; Joyce, C; Sanford, A1
Alshaer, M; Burch, G; Carson, J; Drabick, Z; Mazirka, P; Peloquin, C1
Dash, S; Gupta, K1
Azimi, L; Rastegar Lari, A1
Arnould, JF; Bouquié, R; Dailly, E; Deslandes, G; Fraissinet, F; Jolliet, P; Le Floch, R; Letard de la Bouralière, MA; Naux, E1
Bahador, A; Esmaeili, D; Jalalvand, N; Kholdi, S; Nasrolahei, M; Saghi, H; Zahedi, B1
Adabi, M; Gholami, A; Majidpour, َ; Rasouli-Kouhi, S; Talebi-Taher, M1
Briscoe, SE; Lipman, J; McWhinney, BC; Muller, MJ; Paratz, J; Patel, BM; Paterson, D; Roberts, JA; Rudd, M; See, NC; Ungerer, J1
Economou, CJ; Jamal, JA; Lipman, J; Roberts, JA1
Cross, SE; Dalley, AJ; Lipman, J; Roberts, MS; Rudd, M; Venkatesh, B1

Reviews

1 review(s) available for beta-lactams and Burns

ArticleYear
Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation.
    Current opinion in critical care, 2012, Volume: 18, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Burns; Critical Illness; Drug Resistance, Multiple, Bacterial; Extracorporeal Membrane Oxygenation; Glycoproteins; Humans; Intensive Care Units; Renal Replacement Therapy

2012

Other Studies

9 other study(ies) available for beta-lactams and Burns

ArticleYear
Review of culprit drugs associated with patients admitted to the burn unit with the diagnosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Syndrome.
    Burns : journal of the International Society for Burn Injuries, 2022, Volume: 48, Issue:7

    Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; beta-Lactams; Burn Units; Burns; Humans; Retrospective Studies; Stevens-Johnson Syndrome; Trimethoprim, Sulfamethoxazole Drug Combination

2022
Experience with Implementing a Beta-lactam Therapeutic Drug Monitoring Service in a Burn Intensive Care Unit: A Retrospective Chart Review.
    Journal of burn care & research : official publication of the American Burn Association, 2023, 01-05, Volume: 44, Issue:1

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Burns; Critical Illness; Drug Monitoring; Humans; Intensive Care Units; Retrospective Studies

2023
Efficacy of newer β lactams/ β lactamase inhibitors for treatment of multidrug resistant gram negative infections in burn patients.
    Burns : journal of the International Society for Burn Injuries, 2019, Volume: 45, Issue:7

    Topics: Acinetobacter baumannii; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Burns; Carbapenem-Resistant Enterobacteriaceae; Cephalosporins; Drug Combinations; Drug Development; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa

2019
Collateral sensitivity between aminoglycosides and beta-lactam antibiotics depends on active proton pumps.
    Microbial pathogenesis, 2017, Volume: 112

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactams; Burns; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Genes, Bacterial; Genes, MDR; Gentamicins; Humans; Imipenem; Iran; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymerase Chain Reaction; Proton Pumps; Pseudomonas aeruginosa; Pseudomonas Infections

2017
Pharmacokinetics of ertapenem in burns patients.
    International journal of antimicrobial agents, 2013, Volume: 42, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Burns; Ertapenem; Humans; Male; Middle Aged; Models, Statistical; Plasma; Prospective Studies; Young Adult

2013
Distribution of bla(OXA-23), ISAba , Aminoglycosides resistant genes among burned & ICU patients in Tehran and Sari, Iran.
    Annals of clinical microbiology and antimicrobials, 2014, Sep-25, Volume: 13

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Burns; Critical Illness; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Intensive Care Units; Iran; Microbial Sensitivity Tests; Polymerase Chain Reaction

2014
Role of efflux pump inhibitor in decreasing antibiotic cross-resistance of Pseudomonas aeruginosa in a burn hospital in Iran.
    Journal of infection in developing countries, 2016, Jun-30, Volume: 10, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Biological Transport, Active; Burns; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Iran; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections

2016
Therapeutic drug monitoring of beta-lactam antibiotics in burns patients--a one-year prospective study.
    Therapeutic drug monitoring, 2012, Volume: 34, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Body Surface Area; Burns; Creatinine; Drug Monitoring; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Time Factors

2012
Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Burns; Cephalothin; Debridement; Drug Administration Schedule; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam

2007